These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 25233625)

  • 1. [Methods for the study of drug transporters].
    Li D; Sheng L; Li Y
    Yao Xue Xue Bao; 2014 Jul; 49(7):963-70. PubMed ID: 25233625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Intestinal absorption and renal excretion mediated by transporters and the relationship with drug-drug interaction].
    Zhang J; Liu KX
    Yao Xue Xue Bao; 2010 Sep; 45(9):1089-94. PubMed ID: 21351563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transporter-mediated drug-drug interactions.
    Zhang L; Huang SM; Lesko LJ
    Clin Pharmacol Ther; 2011 Apr; 89(4):481-4. PubMed ID: 21423238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo approaches to characterize transporter-mediated disposition in drug discovery.
    Feng B; Varma MV; Costales C; Zhang H; Tremaine L
    Expert Opin Drug Discov; 2014 Aug; 9(8):873-90. PubMed ID: 24857286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of janus kinase inhibitors with drug transporters and consequences for pharmacokinetics and toxicity.
    Alim K; Bruyère A; Lescoat A; Jouan E; Lecureur V; Le Vée M; Fardel O
    Expert Opin Drug Metab Toxicol; 2021 Mar; 17(3):259-271. PubMed ID: 33292029
    [No Abstract]   [Full Text] [Related]  

  • 6. Transporters and drug-drug interactions: important determinants of drug disposition and effects.
    König J; Müller F; Fromm MF
    Pharmacol Rev; 2013 Jul; 65(3):944-66. PubMed ID: 23686349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of Hepatic Transporters in Clinical Disposition of Drugs and Their Metabolites.
    Patel M; Taskar KS; Zamek-Gliszczynski MJ
    J Clin Pharmacol; 2016 Jul; 56 Suppl 7():S23-39. PubMed ID: 27385177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of transporters in drug development: Current status and contemporary issues.
    Lee SC; Arya V; Yang X; Volpe DA; Zhang L
    Adv Drug Deliv Rev; 2017 Jul; 116():100-118. PubMed ID: 28760687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of transporters in hepatic drug disposition].
    Gao CY; Chen XY; Zhong DF
    Yao Xue Xue Bao; 2012 May; 47(5):565-72. PubMed ID: 22811997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Environmental chemicals as substrates, inhibitors or inducers of drug transporters: implication for toxicokinetics, toxicity and pharmacokinetics.
    Fardel O; Kolasa E; Le Vee M
    Expert Opin Drug Metab Toxicol; 2012 Jan; 8(1):29-46. PubMed ID: 22176607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overview of Transporters in Pharmacokinetics and Drug Discovery.
    Zhang Y
    Curr Protoc Pharmacol; 2018 Sep; 82(1):e46. PubMed ID: 30168909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Drug Transporters in the Pharmacokinetics of Antibiotics.
    Hua WJ; Hua WX; Jian Z; Wei PH; Ni LY; Hua LY; Wen CD; Ying Z; Li C
    Curr Drug Metab; 2016; 17(8):799-805. PubMed ID: 27364830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transporters in Drug Development: Scientific and Regulatory Considerations.
    Zhang L; Huang SM; Reynolds K; Madabushi R; Zineh I
    Clin Pharmacol Ther; 2018 Nov; 104(5):793-796. PubMed ID: 30270426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of organic cation transporters in drug-drug interaction.
    Koepsell H
    Expert Opin Drug Metab Toxicol; 2015; 11(10):1619-33. PubMed ID: 26206523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug trafficking: recent advances in therapeutics and disease.
    Sprowl JA; Sparreboom A
    Clin Pharmacol Ther; 2012 Nov; 92(5):531-4. PubMed ID: 23085872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The transporters of intestinal tract and their study methods].
    Liu ZH; Liu KX
    Yao Xue Xue Bao; 2011 Apr; 46(4):370-6. PubMed ID: 21751488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of Human Membrane Transporters: Drug Disposition and Pharmacogenetics.
    Mooij MG; Nies AT; Knibbe CA; Schaeffeler E; Tibboel D; Schwab M; de Wildt SN
    Clin Pharmacokinet; 2016 May; 55(5):507-24. PubMed ID: 26410689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of transporter-mediated drug absorption, distribution, elimination and drug interactions in antimicrobial chemotherapy.
    Tsuji A
    J Infect Chemother; 2006 Oct; 12(5):241-50. PubMed ID: 17109086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impacts of Drug Interactions on Pharmacokinetics and the Brain Transporters: A Recent Review of Natural Compound-Drug Interactions in Brain Disorders.
    Khadka B; Lee JY; Park EK; Kim KT; Bae JS
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent Advances in Understanding of Kinetic Interplay Between Phase II Metabolism and Efflux Transport.
    Wang S; Xing H; Zhao M; Lu D; Li Z; Dong D; Wu B
    Curr Drug Metab; 2016; 17(10):922-929. PubMed ID: 27894245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.